Chris Dewey

TriFlo is focused on taking to clinical trials a unique minimally invasive transcatheter solution to treat tricuspid valve regurgitation.

MIVI Neuroscience, (MIVI) is an innovative medical device company that aims to achieve life-giving results for an increasing number of patients experiencing acute ischemic stroke (AIS). We accomplish this through proprietary technology designed in collaboration with physicians to vastly improve the safety and efficacy of interventional AIS therapy.

Cephea Valve Technologies, Inc. is a company based out of 3050 Three Springs Court, San Jose, California, United States.

Auris Health was acquired by Ethicon, part of the Johnson & Johnson Medical Devices Companies, in 2019. This page is no longer active. Please follow us at www.linkedin.com/company/ethicon/

Shockwave Medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. Inspired by 30-years of safety and efficacy in kidney stone treatment, our Intravascular Lithotripsy family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. IVL catheters use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. An integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. Stay connected with us at www.ShockwaveMedical.com and on Twitter @ShockwaveIVL

DermaSensor is a Miami-based health technology company designing tools to better equip primary care providers for skin cancer checks. The company started commercial pilots in 2021 in Australia and the product is also CE Marked. The DermaSensor device FDA submission is pending review; not available for sale in the United States.

As of January 5, 2021, OrthoSensor is now part of Stryker. With technologies spanning the continuum of care in total joint replacement, together, Stryker and OrthoSensor, Inc. will empower surgeons with intelligent devices and comprehensive data-driven solutions. This page is no longer current. Connect with us on LinkedIn at Stryker Joint Replacement. https://www.linkedin.com/showcase/stryker-joint-replacement/ OrthoSensor, Inc., a leader in Sensor-Assisted Total Knee Arthroplasty, develops and commercializes intelligent orthopaedic devices and data services that provide quantitative feedback to surgeons and hospitals. The company’s intelligent orthopaedic devices utilize advanced proprietary sensor and communications technologies, coupled with the company’s innovative software products, to facilitate evidence-based decisions in orthopaedic surgery – with the goal of improving patient outcomes and potentially reducing the cost of treating musculoskeletal disease. OrthoSensor® and VERASENSE™ are trademarks of OrthoSensor, Inc. Social Media Disclaimer: http://www.orthosensor.com/disclaimer

MAKO Surgical Corp. is a medical device company that markets its advanced robotic solution and implants for minimally invasive orthopedic knee procedures. The RIO® Robotic Arm Interactive Orthopedic System includes a platform that utilizes tactile-resistance and patient-specific visualization to prepare the knee joint for the insertion and alignment of resurfacing implants through a keyhole incision. This FDA-cleared surgeon-interactive robotic arm system allows surgeons to provide an innovative tissue-sparing bone resurfacing therapy called MAKOplasty ® to a large, yet underserved patient-specific population suffering from early to mid-stage osteoarthritis knee disease. MAKO has an intellectual property portfolio of more than two hundred licensed or owned patent applications relating to the areas of computer assisted surgery, haptics, robotics, and implants.

TriFlo is focused on taking to clinical trials a unique minimally invasive transcatheter solution to treat tricuspid valve regurgitation.

We invest in technology that disrupts the medical industry and fuels innovation. Securities offered through Ceros Financial Services, Inc. Member FINRA/SIPC Ceros Capital Markets is a division of Ceros Financial Services, Inc. Member FINRA/SIPC The content of this site is intended to be general in nature and is not an offer to buy, sell or participate in any security, securities product or investment strategy. Please visit our website for more important information.

Ceros Financial Services, Inc. is a financial services firm headquartered in Rockville, MD. Please see the website (http://www.cerosfs.com) for more information about the company and the services it provides.

MIVI Neuroscience, (MIVI) is an innovative medical device company that aims to achieve life-giving results for an increasing number of patients experiencing acute ischemic stroke (AIS). We accomplish this through proprietary technology designed in collaboration with physicians to vastly improve the safety and efficacy of interventional AIS therapy.